- Abstract:
-
BACKGROUND AND OBJECTIVES: Reducing LDL cholesterol (LDL-C) with statin-based therapy reduces the risk of major atherosclerotic events among patients with CKD, including dialysis patients, but the effect of lowering LDL-C on vascular access patency is unclear. DESIGN, SETTING, PARTICIPANTS, and MEASUREMENTS: The Study of Heart and Renal Protection (SHARP) randomized patients with CKD to 20 mg simvastatin plus 10 mg ezetimibe daily versus matching placebo. This study aimed to explore the effec...
Expand abstract - Publication status:
- Published
- Journal:
- Clinical journal of the American Society of Nephrology : CJASN
- Volume:
- 9
- Issue:
- 5
- Pages:
- 914-919
- Publication date:
- 2014-05-05
- DOI:
- EISSN:
-
1555-905X
- ISSN:
-
1555-9041
- URN:
-
uuid:633d6d1e-1426-45df-aa86-2647e2c9af9a
- Source identifiers:
-
457673
- Local pid:
- pubs:457673
- Language:
- English
- Keywords:
- Copyright date:
- 2014
Journal article
The effect of lowering LDL cholesterol on vascular access patency: post hoc analysis of the Study of Heart and Renal Protection.
Actions
Authors
Bibliographic Details
Item Description
Terms of use
Metrics
Altmetrics
Dimensions
If you are the owner of this record, you can report an update to it here: Report update to this record